Allopurinol
- Product NDC
- 16714-577
- 11-digit product format
- 167140577
- Labeler code
- 16714
- Product ID
- 16714-577_0f560d11-3ba5-4dd4-8c20-ed9b43bfd69a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA204467
- Marketing category
- ANDA
- Marketing start
- 2022-07-01
- Substance
- ALLOPURINOL
- Active strength
- 300 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Allopurinol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALLOPURINOL | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 63CZ7GJN5I |
| Rxcui | 197319, 197320 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16714-577-01 | Allopurinol | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 16714-577-02 | Allopurinol | 500 in 1 BOTTLE | TABLET | 500 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-577 | ALLOPURINOL TABLET [NORTHSTAR RXLLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240915_95a1ca8c-9855-4b11-92cd-6fdc144f0d3b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-577-01 | 16714057701 | 100 TABLET in 1 BOTTLE (16714-577-01) | 100 tablet | 2022-07-01 | 0000-00-00 | No | No | Current |
| 16714-577-02 | 16714057702 | 500 TABLET in 1 BOTTLE (16714-577-02) | 500 tablet | 2022-07-01 | 0000-00-00 | No | No | Current |